Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.800 | None | 0.977 | 301 | 32 | 1991 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.500 | None | 0.974 | 267 | 4 | 1987 | 2020 | ||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
disease | 0.100 | None | 0.975 | 238 | 0 | 1975 | 2020 | |||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
disease | 0.100 | None | 0.975 | 238 | 0 | 1975 | 2020 | |||||||||
|
immunoglobulin heavy variable 3-69-1 (pseudogene) | 0.561 | 0.654 |
|
disease | 0.100 | None | 0.974 | 233 | 0 | 1989 | 2020 | |||||||||
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene) | 0.566 | 0.654 |
|
disease | 0.100 | None | 0.968 | 187 | 0 | 1989 | 2020 | |||||||||
|
zeta chain of T cell receptor associated protein kinase 70 | 0.497 | 0.769 | 0.88 |
|
disease | 0.100 | None | 0.977 | 175 | 0 | 2002 | 2019 | ||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
disease | 0.100 | None | 0.971 | 172 | 0 | 1993 | 2020 | |||||||||
|
CD38 molecule | 0.407 | 0.885 | 2.3E-06 |
|
disease | 0.100 | None | 0.964 | 139 | 2 | 1991 | 2019 | ||||||||
|
Bruton tyrosine kinase | 0.464 | 0.808 | 1.00 |
|
disease | 0.400 | None | 0.982 | 114 | 2 | 2011 | 2020 | ||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
disease | 0.100 | None | 0.991 | 109 | 0 | 1990 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.700 | None | 0.966 | 88 | 4 | 1998 | 2019 | ||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
disease | 0.100 | None | 1.000 | 83 | 0 | 1990 | 2020 | ||||||||
|
T cell leukemia/lymphoma 1A | 0.558 | 0.500 | 5.7E-10 |
|
disease | 0.100 | None | 0.988 | 81 | 0 | 1988 | 2020 | ||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
disease | 0.100 | None | 1.000 | 80 | 0 | 1990 | 2020 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.975 | 79 | 0 | 2009 | 2020 | ||||||||
|
T cell leukemia/lymphoma 1B | 0.561 | 0.500 | 1.0E-02 |
|
disease | 0.100 | None | 0.986 | 74 | 0 | 1988 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.985 | 67 | 0 | 2008 | 2020 | ||||||||
|
CD40 ligand | 0.414 | 0.846 | 0.72 |
|
disease | 0.100 | None | 0.980 | 49 | 0 | 1975 | 2019 | ||||||||
|
MCL1 apoptosis regulator, BCL2 family member | 0.430 | 0.808 | 0.96 |
|
disease | 0.100 | None | 1.000 | 48 | 0 | 1998 | 2019 | ||||||||
|
Fc fragment of IgE receptor II | 0.560 | 0.654 | 7.6E-12 |
|
disease | 0.100 | None | 1.000 | 47 | 0 | 1991 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 0.884 | 43 | 0 | 1988 | 2018 | ||||||||
|
leukocyte associated immunoglobulin like receptor 1 | 0.569 | 0.692 | 3.3E-07 |
|
disease | 0.100 | None | 0.976 | 42 | 0 | 1989 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 1.000 | 42 | 0 | 2008 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.400 | None | 1.000 | 41 | 0 | 2008 | 2020 |